Catalyst Wire Dossier Catalyst Wire Dossier

Kleb4V

Klebsiella pneumoniae tetravalent bioconjugate vaccine · LimmaTech Biologics AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kleb4V, covering 2022-10-04 to 2022-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) [Phase 1, Phase 2]

See pricing